Rhenman & Partners Asset Management AB Acquires 4,600 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Rhenman & Partners Asset Management AB increased its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 15.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,200 shares of the company's stock after purchasing an additional 4,600 shares during the period. Rhenman & Partners Asset Management AB owned approximately 0.06% of Molina Healthcare worth $9,954,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Wellington Management Group LLP raised its position in shares of Molina Healthcare by 7.4% in the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after buying an additional 181,073 shares in the last quarter. State Street Corp raised its position in Molina Healthcare by 0.5% during the third quarter. State Street Corp now owns 2,614,311 shares of the company's stock valued at $900,787,000 after purchasing an additional 13,001 shares in the last quarter. Geode Capital Management LLC lifted its stake in Molina Healthcare by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Norges Bank bought a new position in shares of Molina Healthcare in the 4th quarter valued at $134,675,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Molina Healthcare by 2.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock worth $116,443,000 after buying an additional 10,002 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Truist Financial lowered their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. Barclays lowered their target price on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a report on Friday, February 7th. Stephens reissued an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a research report on Thursday, February 6th. Guggenheim began coverage on Molina Healthcare in a research report on Wednesday. They set a "neutral" rating on the stock. Finally, UBS Group lowered their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. Eight analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $350.75.

Insider Activity at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Stock Performance

MOH traded up $2.34 during midday trading on Thursday, reaching $342.43. The company had a trading volume of 291,997 shares, compared to its average volume of 648,977. The business has a 50-day moving average price of $309.45 and a two-hundred day moving average price of $308.20. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $383.58. The stock has a market cap of $18.73 billion, a PE ratio of 16.73, a P/E/G ratio of 1.06 and a beta of 0.70.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, sell-side analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.